Related Experiment Video
Updated: Sep 12, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Adding salt to foods increases the risk of metabolic dysfunction-associated steatotic liver disease
Han Chen1,2, Xujun Zhang3, Shujuan Lin4
1Department of Epidemiology and Biostatistics, School of Public Health and Nursing, Hangzhou Normal University, Hangzhou, China.
Background:
Although salt intake has been linked to multiple cardiometabolic diseases, whether the frequency of adding salt to foods, a reasonable proxy for long-term salt intake, is related to metabolic dysfunction-associated steatotic liver disease (MASLD) incidence remains unknown.
Methods:
This prospective study included 494,110 UK Biobank participants (mean age 56.5 years) who were free of MASLD at baseline. Participants were followed for a median of 13.6 years. Cox proportional hazards models were used to examine the relationship between the frequency of adding salt to foods and incident MASLD. Mediation analyses explored the role of blood biomarkers, and interaction analyses assessed whether genetic factors modify this association.
Results:
Here, we show that among the cohort, 7171 participants develop MASLD during follow-up. Compared to people who never or rarely adding salt, those who sometimes, usually, and always add salt to foods have 7%, 20%, and 35% higher risk, respectively. This association is stronger in people with normal body mass index and those who frequently drink alcohol. Blood markers of inflammation and metabolism, such as C-reactive protein, insulin-like growth factor-1, triglycerides, and urate, partially mediate this relationship. A significant interaction is observed, with PNPLA3 genetic susceptibility amplifying the MASLD risk associated with frequently adding salt to foods.
Conclusions:
A higher frequency of adding salt to foods is associated with increased MASLD risk. Reducing table salt use represents a simple, actionable strategy for disease prevention, particularly for genetically susceptible individuals.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Responses to Salt Stress
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

